25.11.2024 – 13:52Helmholtz Zentrum MünchenInceptor Regulates Insulin Homeostasis: A New Approach for Diabetes Therapiesmehr
16.10.2024 – 14:00ARTTIC Innovation GmbHEvent Announcement: VIROFIGHT Hybrid SymposiumRegister HereEin Dokumentmehr
24.09.2024 – 12:25RHEACELL GmbH und Co. KGRHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVUmehr
09.09.2024 – 09:06Sysmex Europe SE2Fundació Puigvert validates a new tool capable of selecting the most suitable antibiotic for uncomplicated urinary tract infections within 45 minutes.Visit our website!Ein Dokumentmehr
04.09.2024 – 15:13Fördergesellschaft IZB mbH2Record financing rounds at the Munich biotech hubFind out more about the 40+ biotech start-ups at the IZBEin Dokumentmehr
28.08.2024 – 07:34STADA Arzneimittel AGPress release: STADA continues strong growth journey in the first half of 2024Ein Dokumentmehr
17.07.2024 – 09:42Grünenthal Group2Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patientsmehr
28.05.2024 – 14:05ARTTIC Innovation GmbHcanSERV invites applications for "Revolutionising Cancer Patient Care"canSERV Challenge CallEin Dokumentmehr
28.05.2024 – 14:00ARTTIC Innovation GmbH3canSERV invites applications for "Revolutionising Cancer Patient Care"canSERV CallEin Dokumentmehr
29.04.2024 – 13:00Gerresheimer AG2Gerresheimer partners with RxCap to offer connected adherence solutionsmehr
10.04.2024 – 11:00Dr. Reddy's Laboratories SADr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatmentmehr
14.03.2024 – 07:31STADA Arzneimittel AGPress release: STADA continues with double-digit sales and profit growth in 2023Ein Dokumentmehr
28.02.2024 – 15:00RHEACELL GmbH und Co. KGResearch Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘mehr
28.02.2024 – 13:00LTS Lohmann Therapie-Systeme AGFirst product based on LTS’ Sorrel(TM) wearable drug delivery platform launched in the USmehr
28.02.2024 – 11:07Helmholtz Zentrum MünchenRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Targetmehr
22.02.2024 – 13:23Helmholtz Zentrum MünchenTherapeutic Vaccine for Chronic Hepatitis B Enters Clinical TrialMore information on the therapeutic vaccine TherVacBmehr
26.01.2024 – 13:50Biomay AGBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapymehr
24.01.2024 – 11:00SHL MedicalSHL Medical partners with SteriPack Group to set up final assembly servicemehr
09.01.2024 – 11:02STADA Arzneimittel AGPress release: Zuellig Pharma becomes STADA Philippines’ exclusive distribution partnerEin Dokumentmehr
19.12.2023 – 13:00LTS Lohmann Therapie-Systeme AGLTS receives $4.3 Million grant for the development of contraceptive Microneedle Array Patchesmehr
06.12.2023 – 16:00LTS Lohmann Therapie-Systeme AGLTS receives grant of $1.2 Million to support the development of thermostable mRNA formulations for Microneedle Array Patchesmehr
23.11.2023 – 20:15Fraunhofer-Institut für Produktionstechnologie IPTPooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systemsPress release and imagesmehr
22.11.2023 – 17:08STADA Arzneimittel AGPress release: STADA strikes partnership with CR Sanjiu in China to drive growth of its cough and cold portfolioEin Dokumentmehr
13.11.2023 – 13:38Biomay AGBiomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Servicesmehr
17.10.2023 – 11:00SHL MedicalSHL Medical and Lifecore Biomedical enter co-marketing partnership agreementmehr
30.08.2023 – 12:28STADA Arzneimittel AG2Press release : People with Parkinson’s experience variations in effects of oral medicines, but lack advice, international survey revealsEin Dokumentmehr
15.08.2023 – 07:01STADA Arzneimittel AG2Press release: STADA's excellent results in H1 2023 indicate a record annual profit of €1 bn, driven by Consumer Healthcare and SpecialtyEin Dokumentmehr
05.07.2023 – 17:15Helmholtz Zentrum MünchenPotentiating Cancer Vulnerability to Ferroptosis: Off-Targeting Effects of DHODH Inhibitorsmehr